TETRALOGY OF FALLOT
Clinical trials for TETRALOGY OF FALLOT explained in plain language.
Never miss a new study
Get alerted when new TETRALOGY OF FALLOT trials appear
Sign up with your email to follow new studies for TETRALOGY OF FALLOT, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New heart valve implanted through blood vessel shows promise
Disease control OngoingThis study is testing a new heart valve called the PULSTA TPV for people with a leaky or narrowed pulmonary valve, often due to a heart condition present from birth. The valve is designed to be implanted through a blood vessel without needing open-heart surgery. Researchers are c…
Matched conditions: TETRALOGY OF FALLOT
Phase: NA • Sponsor: Taewoong Medical Co., Ltd. • Aim: Disease control
Last updated Apr 04, 2026 06:36 UTC
-
New heart valve device offers hope for those born with heart defects
Disease control OngoingThis study is testing a new medical device designed to help people born with poorly functioning pulmonary heart valves. The device combines a support structure with a replacement valve, delivered through a catheter without open-heart surgery. Researchers want to see if this appro…
Matched conditions: TETRALOGY OF FALLOT
Phase: NA • Sponsor: Edwards Lifesciences • Aim: Disease control
Last updated Apr 03, 2026 14:41 UTC
-
New heart valve device tested for congenital defects
Disease control OngoingThis study is testing the safety and performance of a new medical device called the GORE PV1. It is designed to replace a leaky or narrowed pulmonary valve and rebuild part of the heart's structure in people born with certain heart defects. The study will follow 15 participants, …
Matched conditions: TETRALOGY OF FALLOT
Phase: NA • Sponsor: W.L.Gore & Associates • Aim: Disease control
Last updated Mar 30, 2026 14:35 UTC
-
New heart valve device under watch after approval
Disease control OngoingThis study is monitoring the safety and performance of a recently approved heart valve device for people born with specific heart defects. It involves 150 participants who need a new pulmonary valve. The goal is to see how well the device works in real-world use after it received…
Matched conditions: TETRALOGY OF FALLOT
Sponsor: Edwards Lifesciences • Aim: Disease control
Last updated Mar 30, 2026 14:32 UTC